Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Shixian Lian"'
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background The serum systemic inflammation biomarkers have been established as predictors of prognosis in gastric cancer (GC) patients, but their prognostic value in human immunodeficiency virus (HIV)-infected patients with GC has not been w
Externí odkaz:
https://doaj.org/article/19b3e243f4324d8d936af7bd341f7289
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2023 (2023)
Background. The serum systemic inflammation biomarkers are known predictors of colorectal cancer (CRC) patient prognosis. However, their significance in human immunodeficiency virus (HIV)-infected patients with CRC has not been studied. To address th
Externí odkaz:
https://doaj.org/article/271f67f2aadb4ca893789d3d6d41245e
Autor:
Yebo Shao, Shixian Lian, Jiajia Zheng, Hanxing Tong, Jiongyuan Wang, Jing Xu, Wenshuai Liu, Guoxiang Hu, Yong Zhang, Junyi He
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 25, Iss , Pp 264-276 (2021)
Emerging evidence has shown that long non-coding RNAs (lncRNAs) play crucial roles in human cancers. However, systematic characterization of lncRNAs and their roles in gastrointestinal stromal tumor (GIST) therapy have been lacking. We performed high
Externí odkaz:
https://doaj.org/article/76ff6ad971714ea8a9b5c506fa20fccb
Publikováno v:
Viruses, Vol 15, Iss 7, p 1490 (2023)
Background: China initiated its national free antiretroviral therapy program in 2004 and saw a dramatic decline in mortality among the population with HIV. However, the morbidity of non-AIDS-defining cancers such as breast cancer is steadily growing
Externí odkaz:
https://doaj.org/article/cacdf55e89ce43788ccd37ab3afefe97
Autor:
Jie Tao, Lin Yin, Ao Wu, Jiaoli Zhang, Jingpu Zhang, Huichun Shi, Siyuan Liu, Liangfei Niu, Li Xu, Yanling Feng, Shixian Lian, Lei Li, Liyan Zeng, Xianmin Meng, Xiaohui Zhou, Tiefu Liu, Lijun Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundChronic inflammation contributes to approximately 20% of cancers; the underlying mechanisms are still elusive. Here, using an animal model of colitis to colon-cancerous transformation, we demonstrated that endoplasmic reticulum (ER) stress
Externí odkaz:
https://doaj.org/article/6a561aadb5e543879539b65686d823a2
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundTumor-infiltrating lymphocytes (TILs) and expression of programmed cell death 1 (PD-1)/programmed death ligand-1 (PD-L1) are crucial for antitumor immunity. However, the status remains undetermined in HIV-infected colorectal cancer (CRC), l
Externí odkaz:
https://doaj.org/article/5663357b5d6441b6871b242ff6a435d6
Autor:
Shixian Lian1, Siyuan Liu2 zhanglijun@shphc.org.cn, Ao Wu1, Lin Yin1, Lei Li1, Liyan Zeng1, Mingkun Zhao1, Lijun Zhang1
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 12, p3724-3737. 14p.
Autor:
Junyi He, Jiong-Yuan Wang, Hanxing Tong, Shixian Lian, Yong Zhang, W. Liu, Jing Xu, Guoxiang Hu, Yebo Shao, Jiajia Zheng
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 25, Iss, Pp 264-276 (2021)
Molecular Therapy: Nucleic Acids, Vol 25, Iss, Pp 264-276 (2021)
Emerging evidence has shown that long non-coding RNAs (lncRNAs) play crucial roles in human cancers. However, systematic characterization of lncRNAs and their roles in gastrointestinal stromal tumor (GIST) therapy have been lacking. We performed high
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 24(5)
To evaluate the efficacy and safety of cisplatin and nimotuzumab combined with concurrent chemoradiotherapy on locally advanced cervical cancer.92 patients with cervical cancer in moderate and advanced stages treated in Shanghai Public Health Clinica
Autor:
Zehuan Li, G. H. Hu, Ying Jiang, X. X. Jiao, Weiqi Lu, Zi-Xing Chen, Shixian Lian, Yi-Ran Qiu, Yingyuan Zhang, S. Y. Lin, L. Deng
Publikováno v:
Neoplasma. 67(4)
Breast cancer, especially triple-negative breast cancer, is one of the deadliest cancers in women. To date, there is a lack of a good therapeutic regimen for it. PPARγ has been reported to be a tumor suppressor and could be activated by many agonist